Navigation Links
Jim Deal Appointed to MedCath's Board of Directors
Date:8/10/2009

CHARLOTTE, N.C., Aug. 10 /PRNewswire-FirstCall/ -- MedCath Corporation (Nasdaq: MDTH), a healthcare provider focused on high acuity healthcare services, predominately the diagnosis and treatment of cardiovascular disease, today announced that James "Jim" Deal has been appointed to its board of directors.

Deal is an accomplished health care services CEO. Some of his career highlights:

  • Since 2006, he's led Hospice Compassus of Brentwood, Tenn., co-founding a company that's become a leading hospice services provider, serving about 2,700 patients daily at 53 locations in 15 states.
  • From 2002 to 2006, he served as chairman and CEO of INSPIRIS in Nashville, Tenn., which manages the health care of the frail elderly. Deal transformed the business model of the company and made it profitable.
  • He served as president and CEO of the Center for Diagnostic Imaging in Minneapolis for three years, expanding same store growth and using existing cash flow to triple the number of locations.
  • He spent 15 years as president of Diabetes Treatment Centers of America, helping grow the company into one of the nation's leading providers of disease and care management services in the country.
  • He's served as a CEO or executive at several hospitals nationwide.

Deal has also been on the board of directors for AmSurg Corp. in Nashville since 1992, chairing the audit committee since 1999, and he previously spent three years on the board of the Pediatric Nursing Services of America. He earned a master's of Public Administration in Health Services Administration from the University of Arizona, and a bachelor's of business in economics from Western Illinois University.

"Jim has a proven record of being able to help companies grow, and I'm excited that he will bring that insight to our board of directors," said Board Chairman John Casey. "He possesses strategic skills, leadership traits and a wealth of operational, financial, and corporate development experience that will be a tremendous benefit."

Executive search firm Caldwell Partners assisted MedCath's Governance and Nominating Committee with the selection.

MedCath Corporation, headquartered in Charlotte, N.C., is a healthcare provider focused on high acuity services with the diagnosis and treatment of cardiovascular disease being a primary service offering. MedCath owns an interest in and operates nine hospitals with a total of 755 licensed beds, located in Arizona, Arkansas, California, Louisiana, New Mexico, South Dakota, and Texas. MedCath is in the process of developing its tenth hospital, which is anticipated to open in fall 2009, in Kingman, Ariz. In addition, MedCath and its subsidiary MedCath Partners provide services in diagnostic and therapeutic facilities in various states.


'/>"/>
SOURCE MedCath Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
2. William Moore Appointed to IRIDEX Board of Directors
3. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
4. Katie Hood Appointed Interim Chief Executive Officer of Michael J. Fox Foundation
5. James B. Hawkins Appointed to IRIDEX Board of Directors
6. Bryan R. Rogers Appointed President of Far West Division
7. Theodore A. Boutacoff Appointed President & CEO of IRIDEX
8. Catholic Health Association Disappointed by Failure to Override SCHIP Veto
9. Steven M. Safyer, MD, Appointed President and CEO of Montefiore Medical Center
10. Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
11. Irene Hegeman Richard, MD, Appointed Senior Medical Advisor to The Michael J. Fox Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: